CAPNI Region 1 uses ENP Network to manage On-Demand CE activites and registrations.

Please log in or create an account to access the registration information for Incorporating Recently Approved FLT3 Inhibitors as Maintenance Therapy for Patients With a History of FLT3-Mutated AML.